Skin blood flow after transdermal S-nitrosothio-acetylglucose.

Faisal Khan, Iain Robert Greig, David J Newton, Anthony R Butler, Jill J F Belch

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Abstract

The role of nitric oxide (NO) in skin microvessels is unclear because of the variable effects of NG-monomethyl-L-arginine (L-NMMA) on skin blood flow.1, 2 Although 80–90% of skin blood flow serves a thermoregulatory function, it is the nutritional component that is clinically important. Nitrovasodilators, such as sodium nitroprusside and glyceryl trinitrate, are difficult to study in cutaneous microvessels because they require extensive metabolism before they release NO. S-nitrosothiols release NO and are vasodilators in animals.3 S-nitrosothio-acetylglucose (SNAG) acts as a vasodilator in the isolated rat tail artery.4 We now examine the effects of transdermal application of SNAG on human skin microvessels. We measured skin perfusion with laser doppler imaging and skin oxygenation by lightguide spectrophotometry.
Original languageEnglish
Pages (from-to)410-411
Number of pages2
JournalLancet (London, England)
Volume350
Issue number9075
DOIs
Publication statusPublished - 1 Aug 1997
Externally publishedYes

Fingerprint

Dive into the research topics of 'Skin blood flow after transdermal S-nitrosothio-acetylglucose.'. Together they form a unique fingerprint.

Cite this